Mentice
Company Details
Status: Public
Employees: 101-250
Location:
Odinsgatan 10, Gothenburg, 41103, SE
Type:
sample
Technology:
sample
sample
sample
About: Mentice, founded in 1999 and based in Sweden, is a leader in medical simulation solutions focused on image-guided interventional therapies (IGIT). The company has transitioned from providing endovascular simulators to offering comprehensive IGIT performance solutions aimed at enhancing clinical outcomes through advanced training and procedural optimization. Mentice is publicly traded on Nasdaq First North Growth Market under the ticker MNTC.
The company provides a range of software and hardware simulation solutions designed to improve clinical performance in minimally invasive procedures. Key products include the VIST® series of haptic-enabled simulators for vascular procedures and MIST® systems for basic endovascular training. Mentice also offers portable platforms and integrated performance solutions that optimize workflow and assess clinician competency. The use of haptic feedback technology allows for realistic training in complex interventions.
Mentice collaborates with global medical device companies and healthcare institutions, including notable partnerships with Terumo and Abbott. The company aims for significant annual sales growth and has expanded its geographic reach, including establishing an office in Chicago. Mentice is committed to addressing the demand for safer and more efficient minimally invasive procedures.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Mentice | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.